• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Smokeless Tobacco Treatment Companies

    ID: MRFR/HC/5662-HCR
    90 Pages
    Kinjoll Dey
    September 2025

    Smokeless tobacco treatment typically involves products and interventions designed to help individuals quit or reduce their use of smokeless tobacco products, such as chewing tobacco or snuff.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Smokeless Tobacco Treatment Market

    Smokeless Tobacco Market

     


    Latest Smokeless Tobacco Companies Updates:


    Pfizer (US) announced positive results from a Phase 3 clinical trial of its investigational drug Zyban (bupropion) for smokeless tobacco cessation, demonstrating its efficacy in reducing smokeless tobacco use and promoting abstinence.


    GlaxoSmithKline (UK) received FDA approval for its nicotine patch, NicoDerm CQ, for smokeless tobacco cessation, expanding treatment options for users seeking to quit.CBT-Solutions (US) launched a new digital therapy program specifically designed for smokeless tobacco cessation, offering online cognitive behavioral therapy modules and support resources.


    Quit Genius (UK) partnered with several health organizations to implement its Quit Genius app, a digital smoking and smokeless tobacco cessation program, in community-based settings.


    List of Smokeless Tobacco Key companies in the market:



    • British American Tobacco PLC (U.K)

    • Altria Group, Inc. (U.S.)

    • Japan Tobacco, Inc. (Japan)

    • Imperial Brands PLC (U.K)

    • Swisher International Group, Inc. (U.S.)

    • Swedish Match AB (Sweden)

    • Dharampal Satyapal Limited (India)